Trial Summary
What is the purpose of this trial?The goal of this study is to determine the effectiveness of a direct-to-provider virtual education program ("AF and EKG Interpretation Project ECHO") for primary care providers who manage patients with atrial fibrillation (AF). The main questions this study aims to answer are:
1. Will participants have improvement in knowledge and confidence in managing patients with atrial fibrillation after program completion?
2. Will quality and performance metrics improve at the patient level for program participants?
Participants will be asked to:
* Participate in 12 hours of virtual education sessions over twelve weeks via Zoom.
* Complete a knowledge and confidence assessment online before the program starts and after its completion.
Eligibility Criteria
This trial is for primary care providers (Physicians, Nurse Practitioners, Physician Assistants) who are based in North Carolina and manage adult patients with atrial fibrillation. There are no specific exclusion criteria mentioned, so it appears open to all eligible healthcare professionals within the state.Inclusion Criteria
Primary care provider (Physician, Nurse Practitioner, Physician Assistant) with primary practice in the state of North Carolina
Care for adult population
Exclusion Criteria
Not applicable.
Participant Groups
The study tests a virtual education program called 'AF and EKG Interpretation Project ECHO' designed to improve knowledge and confidence among primary care providers managing atrial fibrillation. It involves 12 hours of Zoom sessions over twelve weeks and assessments before and after the program.
1Treatment groups
Experimental Treatment
Group I: AF and EKG Interpretation Project ECHOExperimental Treatment1 Intervention
All recruited participants participate in the AF and EKG Interpretation Project ECHO educational intervention.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of North Carolina, Chapel HillChapel Hill, NC
Duke UniversityDurham, NC
Wake Forest UniversityWinston-Salem, NC
Loading ...
Who Is Running the Clinical Trial?
University of North Carolina, Chapel HillLead Sponsor
Wake Forest UniversityCollaborator
Duke UniversityCollaborator
Bristol-Myers SquibbIndustry Sponsor